Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,080 | -4,793 | -3,031 | -10,565 | -6,817 |
| Depreciation Amortization | 23 | 16 | 8 | 33 | 25 |
| Accounts payable and accrued liabilities | -170 | -57 | 405 | 113 | 39 |
| Other Working Capital | -1,080 | -931 | 44 | 1,554 | 941 |
| Other Operating Activity | 452 | 264 | -263 | 605 | 452 |
| Operating Cash Flow | $-6,854 | $-5,501 | $-2,837 | $-8,260 | $-5,360 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -1 | -1 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-1 | $-1 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 4,088 | 4,465 |
| Other Financing Activity | 0 | 0 | 0 | -3 | -20 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $4,085 | $4,445 |
| Beginning Cash Position | 11,767 | 11,767 | 11,767 | 15,944 | 15,944 |
| End Cash Position | 4,912 | 6,266 | 8,930 | 11,767 | 15,028 |
| Net Cash Flow | $-6,854 | $-5,501 | $-2,837 | $-4,177 | $-916 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,854 | -5,501 | -2,837 | -8,260 | -5,360 |
| Capital Expenditure | N/A | N/A | N/A | -1 | -1 |
| Free Cash Flow | -6,854 | -5,501 | -2,837 | -8,262 | -5,361 |